Clinical Trials Browser

Interventional × Tetanus Toxoid × Plasma cell × Clear all

NCT02700841 2024-03-12

Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation

Phase 2 Terminated

8 enrolled 8 charts

Multiple Myeloma

NCT00369291 2017-11-29

CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant

Phase 1 Terminated

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Neoplasms, Germ Cell and Embryonal, Neoplasms, Plasma Cell